Facts about CRISPR
- 10
The PAX8 gene, when edited with CRISPR in laboratory thyroid cells, restored normal hormone production in cells derived from patients with congenital hypothyroidism.
- 09
Researchers have used CRISPR to edit human embryos in laboratories since 2015, raising ethical questions that led to an international moratorium on germline editing in 2018.
- 08
Therapeutic trials using CRISPR to treat transthyretin amyloidosis, a rare protein-folding disorder, demonstrated reduction in abnormal protein levels by up to 90 percent in patient blood samples.
- 07
Prime editing, a CRISPR advancement developed by David Liu's team in 2019, can correct mutations with error rates below 1 percent, making it more precise than standard Cas9 editing.
- 06
Multiplexing with CRISPR allows researchers to edit up to 25 different genes simultaneously in a single cell, enabling more complex genetic corrections than single-gene therapies.
- 05
Base editors, a newer CRISPR variant developed around 2016, can convert one DNA letter directly into another without creating double-strand breaks, reducing unwanted mutations.
- 04
Off-target cuts affecting unintended DNA sequences occur in approximately 5-10 percent of CRISPR-Cas9 edits, limiting its clinical safety for certain applications.
- 03
Streptococcus pyogenes bacteria naturally produce the CRISPR-Cas9 system as an immune defense against invading viruses, which scientists repurposed into a precise gene-editing tool.
- 02
Sickle cell disease patients received their first CRISPR treatments in 2023, with early results showing elimination of pain crises in multiple clinical trial participants.
- 01
In 2020, the Nobel Prize in Chemistry was awarded to Jennifer Doudna and Emmanuelle Charpentier for developing CRISPR gene-editing technology.